PARK7 and Parkinson disease: Small-molecule activators such as UCP0045037, UCP0054278, and compound-23 have also been identified via in silico screens and shown to enhance DJ-1’s neuroprotective functions against oxidative stress in animal models of PD and ischemic injury [118].